Human HepG2 Research Bundle

Cellular Engineering Technologies

SKU: CET-BR1003

HepG2 Research Starter Kit

The HepG2 Research Starter Kit provides a complete system for culturing and studying HepG2 hepatocellular carcinoma cells, an essential model for liver function, cancer research, and drug metabolism studies. This kit includes HepG2 Hepatocellular Carcinoma Cells (CR1015-500) and HepG2 Hepatocellular Carcinoma Expansion Media (MR1010), optimized to support high-density cell expansion while preserving hepatic functionality.

Kit Components:

• HepG2 Hepatocellular Carcinoma Cells (CR1015-500)
  • Derived from a liver biopsy of a 14-year-old male donor, widely used for studying liver cancer biology, drug metabolism, and hepatotoxicity.
  • Actively secretes major plasma proteins, including albumin, α2-macroglobulin, α1-anti-trypsin, and plasminogen, making it ideal for protein expression and molecular biology research.
  • Growth Characteristics: Forms clusters with slow initial proliferation, distinguishing it from traditional monolayer cultures.
  • Used extensively for cancer research, drug screening, liver metabolism studies, and genotoxicity testing.
  • Each vial contains ~500,000 cells, shipped on dry ice for optimal viability.
• HepG2 Hepatocellular Carcinoma Expansion Media (MR1010)
  • Specialized formulation designed to support HepG2 cell expansion while maintaining metabolic activity and hepatic functions.
  • Buffered for optimal pH and cellular homeostasis, ensuring high cell viability and proliferation.
  • Compatible with serum supplementation, allowing researchers to customize media conditions.
  • Enhances cell attachment and growth, promoting uniform monolayer formation while sustaining hepatic-specific functionality.

Applications:

• Hepatocellular Carcinoma Research & Drug Discovery
• Liver Metabolism & Toxicology Studies
• Cancer Signaling Pathway Analysis
• Protein Expression & Molecular Biology Research
• Spheroid Genotoxicity Testing & Liver Disease Modeling

The HepG2 Research Starter Kit offers a well-characterized, reproducible, and scalable solution for studying hepatocellular carcinoma, liver disease mechanisms, and drug toxicity. Researchers can leverage this system for high-throughput screening, personalized medicine approaches, and preclinical drug development in liver-related disorders.